SUPN

SUPN Operating Cash Flow (Statement)

$19.91MTTM · USD

Period ending:

SUPN FY Cash from OperationsUSD
SUPN FY Cash from Operations2007-12-31: -$13.98M2008-12-31: -$29.65M2009-12-31: $2.63M2010-12-31: -$32.54M2011-12-31: -$36.19M2012-12-31: -$47.20M2013-12-31: -$57.95M2014-12-31: $7.73M2015-12-31: $32.12M2016-12-31: $66.81M2017-12-31: $114.64M2018-12-31: $128.99M2019-12-31: $143.13M2020-12-31: $138.40M2021-12-31: $127.13M2022-12-31: $116.83M2023-12-31: $111.09M2024-12-31: $171.95M2025-12-31: $47.33M$171.95M-$57.95M
2007-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SUPN operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 19 observations from Dec 31, 2007 to Dec 31, 2025.

Supernus Pharmaceuticals Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
47,331,000
171,951,000
111,085,000
116,826,000
127,127,000
138,399,000
143,129,000
128,986,000
114,640,000
66,812,000
32,123,000
7,733,000
-57,949,000
-47,199,000
-36,185,000
-32,544,000
2,634,000
-29,652,000
-13,980,418

Compare operating cash flow (statement)

All SUPN financial metrics · SUPN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.